CLINICAL_TRIALS
trial_result
· 2022-04-15
Clinical Trial Update: Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines [Phase 3]
Summary
Phase 3 trial comparing Botulax to Botox for moderate to severe crow's feet lines has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hugel | Conditions: Crow's Feet Lines | Phase 3 | Status: COMPLETED